What is Therafin?
Therafin Corporation is a key manufacturer and distributor of rehabilitation and home health care products. Operating through a dedicated network of dealers and distributors, the company serves a critical segment of the healthcare market. Its product portfolio is designed to support patient recovery and enhance quality of life for individuals requiring specialized care, positioning Therafin as a vital contributor to the health and wellness ecosystem.
How much funding has Therafin raised?
Therafin has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Therafin
PPP
Public-Private Partnership
What's next for Therafin?
With the recent influx of capital, Therafin is poised for accelerated growth and strategic development. The large-scale, late-stage funding suggests a focus on scaling operations, expanding market reach, and potentially investing in new product innovation or acquisitions. This strategic investment will likely enable Therafin to further solidify its competitive advantage and capitalize on emerging opportunities within the dynamic rehabilitation and home health care industries, driving enhanced value for stakeholders.
See full Therafin company page
